Siga Technologies INC Capital Expenditures Incurred but Not yet Paid
Siga Technologies INC (SIGA) reported Capital Expenditures Incurred but Not yet Paid of $743.06 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Siga Technologies INC capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $9.20K.
- Siga Technologies INC capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $733.86K.
- Siga Technologies INC capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $0.00.
- Siga Technologies INC capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|---|
| 2026-06-30 | $9.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $743.06K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $733.86K 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |